75 results on '"Warnecke, G"'
Search Results
2. Nonstandard Donor Organs in Pediatric Lung Transplantation have no Negative Impact on Recipients Outcome
3. Aortic Valve-Sparing Operations for Aortic Root Aneurysms in Grown-up Patients with Congenital Heart Disease
4. Impact of Portable Ex Vivo Lung Perfusion with the Organ Care System on Freedom from CLAD
5. Linking Early Donor-Specific Antibodies in Lung Transplant Recipients with Transplant Arteriosclerosis in Humanized Mice
6. Long-term Results of an IgM-Enriched Human Immunoglobulin-Based Therapy for Early Donor-Specific Antibodies after Lung Transplantation
7. Establishing a Simulation Training Platform for Cardiac Surgery Residents: Improving Surgical Training and Technical Skill Assessment
8. Temporary Right Heart Support Following LVAD Implantation in High Risk Patients with Dual Mechanical Support Combining Veno-arterial ECLS and Impella Microaxial Pump
9. Cardiac Transplantation in the VAD Era: Twenty-Year Experience of a Single Center
10. Increasing Frequency of CD127low Regulatory Cells Early after Lung Transplantation is Associated with Improved Freedom from Chronic Lung Allograft Rejection and Survival
11. Computed Tomography for Rejection Monitoring in a Murine Orthotopic Lung Transplantation Model
12. Heart Preservation with the Organ Care System in Germany: Revival in High-Risk Recipients
13. Delayed Non-Myeloablative Irradiation to Induce Allograft Acceptance in a Large Animal Lung Transplantation Model
14. Regulation of Transplant Arteriosclerosis by In Vitro Expanded Human Regulatory T Cells
15. Temporary Right Heart Support Following LVAD Implantation: A Transcutaneous Technique
16. Early Surgical Myocardial Revascularization in Non-ST-Segment Elevation Acute Coronary Syndrome
17. The Impact of Telemonitoring in Patients with Ventricular Assist Device
18. Minimal Invasive Mitral Valve Operations as Cardiac Reoperation
19. Real World Experience with HeartMate 3 - One Year Follow-Up
20. Cytokine Expression in Humanized Mice Reflects Development of Primary Graft Dysfunction in Lung Transplant Recipients
21. Three Years of Experience with an IgM-Enriched Human Intravenous Immunoglobulin-Based Treatment for Patients with Early Donor-Specific Anti-HLA Antibodies after Lung Transplantation
22. In Vivo Development of Transplant Arteriosclerosis in Humanized Mice Reflects BOS in Lung Transplant Recipients and Is Controlled by Autologous Regulatory T Cells
23. Bilateral Lung Transplantation and Post-op VA-ECMO: A Novel Approach for Children with End-Stage Pulmonary Arterial Hypertension (PAH)
24. In Vitro Expansion of Human Regulatory T Cells for Functional Study of Allograft Rejection in a Humanized Mouse Model
25. Leukocytes Transfer Activation of More Severe Rejection from Lung Transplant Recipients with Severe Primary Graft Dysfunction into Humanized Mice are Sensitive to T Cell Regulation
26. Early Survival after Lung Transplantation Is Better in Patients with Higher Frequencies of Regulatory T Cells
27. Treatment with Donor-Specific Alloantigen and Antilymphocyte Mab Three Days after Lung Transplantation Differentially Affects Putative Effector and Regulatory T Cell Populations
28. Early Donor Specific Antibodies after Lung Transplantation Correlate with a Distinct Cellular Immune Phenotype in Peripheral Blood
29. Less Invasive LVAD Surgery in Cardiogenic Shock
30. ‘;Unacceptable’ Human Leukocyte Antigens in Lung Re-transplantation
31. IgM Enriched Human Intravenous Immunoglobulins Based Treatment of Patients with Early Donor Specific Anti-HLA Antibodies after Lung Transplantation
32. Differential Outcomes for Long Term ex vivo Lung Perfusion in a Porcine Model - With or without Red Cells?
33. Lung Transplant Recipients with Elevated Peripheral Blood Counts of CD127low, FoxP3+ and CTLA4+ CD4+CD25high T Cells Develop Less Severe Donor-Specific Transplant Arteriosclerosis in Humanized Mice
34. Transplant Arteriosclerosis in Humanized Mice Reflects Alloantigen Recognition of Lung Transplant Recipients and is Controlled by Autologous Regulatory T Cells
35. The Era Effect on Pediatric Lung Transplantation Outcomes
36. The INSPIRE International Lung Trial with the Organ Care System Technology (OCS™) - Interim Report
37. Prediction of bronchiolitis obliterans syndrome-free survival after two years according to frequencies of regulatory T cells early after lung transplantation
38. Modulation of immune-mediators from donor lungs using the Organ Care System® - a potential mechanism for improved outcome
39. Extending donor criteria in lung transplantation - Donors 70 years and older
40. Cardiopulmonary bypass in a mouse: novel small animal model
41. Pretreatment with donor alloantigen and anti-CD4-antibody 28 days befor lung transplantation leads to immunization rather than tolerance in miniature pigs
42. The INSPIRE international lung trial with the organ care system technology (OCS™) - interim report
43. Donor oxygenation has no impact on postoperative outcome after lung transplantation
44. Early application of C1-Esterase-Inhibitor for primary graft dysfunction following lung transplantation
45. Recipients with higher percent predicted FEV1 early after lung transplantation have more circulating regulatory T cells
46. Microenvironment of preservation solution in lung transplantation – warm perfusion on OCS vs. cold static storage
47. Lung transplantation for pulmonary lymphangioleiomyomatosis: Single-centre experience
48. Living-donor lobar lung transplantation in a 11-year old child on ECMO and mechanical ventilation – a case report
49. Lung transplantation in the age of the lung allocation score
50. Rejection of bronchus transplants in humanized mice is regulated by allogeneic CD4+CD25+ T cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.